Epsilon M&A Deal Report - Devicia & Clarvin
Transaction Multiples for the Valuation of Private Companies
Veranex Group / Devicia & Clarvin
No EMAT :
121276
Announced Date :
30/09/2022
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Veranex Group
Target :
Devicia & Clarvin
Country :
Sweden
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratories
- Engineering and Technical Services > Business Services > Health, Safety, and Environmental Consulting
Business Description :
Devicia is a full-service clinical research organization (CRO) exclusively focused on Medical Devices and In Vitro Diagnostics. > Provide services within Medical Writing, Clinical Investigations and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ns | |||||||
| Current | 
|
ns |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratories » = 135
- Number of EMAT Reports / sub-sector « Health, Safety, and Environmental Consulting » = 42
| Date | Acquirer | Target | Country | Multiples | See details |
| 22/01/2020 | ICON | MedPass International | France | ** | 121267 |
| 28/07/2023 | Funding round backed by IDIA, Sofilaro and C2AD | Agir a dom | France | ** | 120662 |
Source: Epsilon Research / EMAT
